Most Removed from Watchlists

Gilead to deliver more remdesivir to Europe from autumn - WiWo

Gilead Sciences Inc <GILD.O> plans to make more of its drug remdesivir available for Germany and Europe from autumn and will decide how much each country gets based on the rate of infection, the drugmaker's Germany boss told a German magazine. Bettina Bauer, managing director of Gilead in Germany, told WirtschaftsWoche the U.S. drugmaker can increase its worldwide monthly production from currently 190,000 treatment cycles to 2 million treatment cycles in December.

Gilead begins testing inhalable form of remdesivir for COVID-19

The company said the trial, which will enroll about 60 healthy Americans aged between 18 and 45, will test the drug particularly in those cases where the disease has not progressed to require hospitalization. The drug is currently used intravenously and an inhaled formulation would be given through a nebulizer, which could potentially allow for easier administration outside hospitals. Remdesivir was granted emergency use authorization in the United States to treat severe cases of COVID-19 in patients who are hospitalized.

• 
  Remdesivir: Inhaled form of coronavirus drug being tested for use outside of hospitals

  The Independent
• Gilead Begins a Trial of an Inhaled Version of Its Covid-19 Drug for Less-Sick Patients

  Barrons.com

Alcoa Corporation Announces Pricing of Debt Offering

Alcoa Corporation (NYSE:AA) ("Alcoa") announced today that Alcoa Nederland Holding B.V. (the "issuer"), a wholly-owned subsidiary of Alcoa, has priced an offering of $750,000,000 aggregate principal amount of 5.500% senior notes due 2027. The sale of the notes is expected to be completed on July 13, 2020, subject to customary closing conditions.

• 
  Simon Taps Debt Market to Raise $2B on Senior Notes Sale

  Zacks
• 
  Maxeon Solar Technologies Announces Proposed Green Convertible Senior Notes Offering

  PR Newswire

Here's Why Amarin Tumbled 67.7% in the First Half of 2020

The pharma stock collapsed on the threat of generic competition for a drug that launched in December 2019, but the move may have been a bit of an overreaction.

How Constellation Brands Overcame a 75% Sales Slump at Bars and Restaurants

Management recently told investors how it kept the beer business growing through unprecedented challenges.

Analysts Estimate Alcoa (AA) to Report a Decline in Earnings: What to Look Out for

Alcoa (AA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

• 
  Top 5 Stocks With Solid Earnings Beat Potential

  Zacks
• 
  Preferred Bank (PFBC) Expected to Beat Earnings Estimates: Should You Buy?

  Zacks

Sometimes, Valuation Is the Most Important Consideration

It pays to check the valuation before investing because it isn't always the best companies that have upside potential.

• 
  CSIQ vs. FSLR: Which Stock Should Value Investors Buy Now?

  Zacks
• 
  ACHC or THC: Which Is the Better Value Stock Right Now?

  Zacks

Biotech Stock Roundup: REGN Initiates Coronavirus Study, NVAX Surges & More

The biotech sector remains in focus with updates on coronavirus treatments and other pipeline updates.

• 
  CORRECTED-Gilead begins testing inhalable form of remdesivir for COVID-19

  Reuters
• Gilead Starts Testing Inhaled Remdesivir Solution

  TheStreet.com

LabCorp Launches At-Home Coronavirus Test Collection Kit

LabCorp (LH) claims this to be the first digital COVID-19 service that physicians can use to remotely diagnose patients before any surgery or procedure.

• 
  Smiths Detection announces partnership with Attomarker in the development of a Triple Antibody Testing device for COVID-19

  Business Wire
• 
  Dr. Lisa Larkin on COVID-19 antibody testing

  WCPO Cincinnati

Medical vs. Recreational Cannabis: Which Is the Future?

Both cannabis markets are drawing attention. How are these two companies approaching these segments?

• 
  Village Farms International Partners with Dutch Enterprise to Pursue First Legal Recreational Cannabis Market in Europe

  CNW Group
• 
  Panaxia Global Reports Record Revenues of Its Israeli Operations

  CNW Group

Alcoa Corporation Announces Proposed Debt Offering

Alcoa Corporation (NYSE:AA) ("Alcoa") announced today a proposed offering of senior notes (the "notes") by Alcoa Nederland Holding B.V. (the "issuer"), a wholly-owned subsidiary of Alcoa.

• 
  Simon Taps Debt Market to Raise $2B on Senior Notes Sale

  Zacks
• 
  Realty Income Prices 3.25% Senior Notes of $350M at 108.241%

  Zacks

Alcoa Corporation Releases Preliminary Second Quarter 2020 Results

Alcoa Corporation (NYSE: AA) today released preliminary second quarter 2020 results that show the Company’s cash balance rising to more than $950 million with improved productivity and continued stability in operations during the coronavirus pandemic.

• 
  Civista Bancshares, Inc. Announces Second Quarter Earnings Release Date

  PR Newswire
• 
  Lundin Mining to Release Second Quarter 2020 Results July 29, 2020

  CNW Group

Gilead Sciences Presents Survey Findings on PrEP Access and Utilization in the U.S. During COVID-19 Shelter-in-Place Orders

Gilead Sciences, Inc. (Nasdaq: GILD) today announced data presented at the 23rd International AIDS Conference (AIDS 2020: Virtual) evaluating the impact of COVID-19 shelter-in-place orders (SIPOs) and PrEP utilization on HIV prevention strategies and associated risk behaviors. Findings presented included results from an online survey conducted by The American Academy of HIV Medicine (AAHIVM) to understand potential changes in behavior among pre-exposure prophylaxis (PrEP) users and prescribers in the United States during the height of COVID-19 SIPOs. There were 598 total respondents – 409 PrEP users and 189 PrEP prescribers. While most prescribers (90 percent) reported recommending no change in PrEP regimen, about one-third (33 percent) of PrEP users discontinued therapy voluntarily, mostly (85 percent) due to low perceived HIV risk associated with decreased sexual activity. Only 8 percent of those users who discontinued PrEP cited inability to access PrEP medications. Nearly all prescribers (95 percent) were able to successfully prescribe PrEP despite limitations caused by SIPOs.

• 
  Biotech Stock Roundup: REGN Initiates Coronavirus Study, NVAX Surges & More

  Zacks
• 
  Gilead Finally Prices Its Coronavirus Drug — But Is GILD Stock A Buy?

  Investor's Business Daily

Gilead Sciences (GILD) Stock Moves -0.44%: What You Should Know

Gilead Sciences (GILD) closed the most recent trading day at $76.42, moving -0.44% from the previous trading session.

• 
  Wells Fargo (WFC) Gains But Lags Market: What You Should Know

  Zacks
• 
  MasterCard (MA) Dips More Than Broader Markets: What You Should Know

  Zacks

Here's Why Lilly (LLY) Stock is Up Despite Coronavirus Crisis

Lilly's (LLY) shares are up this year mainly due to rapid progress in its efforts to make medicines/antibodies to treat COVID-19.

Zacks.com featured highlights include: Bristol-Myers Squibb, Vale, Gilead Sciences, Kroger and Delek Logistics Partners

Zacks.com featured highlights include: Bristol-Myers Squibb, Vale, Gilead Sciences, Kroger and Delek Logistics Partners

• 
  Bristol Myers Squibb (BMY) Gains As Market Dips: What You Should Know

  Zacks
• 
  The Zacks Analyst Blog Highlights: Alibaba, NVIDIA, Bristol Myers Squibb, PetroChina and S&P Global

  Zacks

Oracle Awarded Framework Agreement from Government of Canada

Oracle announced today the award of a Framework Agreement for the provision of secure cloud services to the Government of Canada. This agreement gives Oracle's Canadian federal government customers the ability to securely store, manage and process sensitive data and applications in Oracle Cloud Infrastructure.

LiveXLive Announces Multi-Year Partnership With Corona Electric Beach For Spring Awakening Music Festival 10th Anniversary Event In 2021

LiveXLive Media (NASDAQ: LIVX) ("LiveXLive"), a global platform for live stream and on-demand audio, video and podcast content in music, comedy, and pop culture, announced today that the Midwest's largest all-electronic music festival -- Spring Awakening Music Festival (SAMF) -- will return home to the City of Chicago for its 10 year anniversary in 2021. The event will be presented by Corona Electric Beach as part of a multi-year deal that included SAMF 2020 and its first virtual experience on July 4 and 5, 2020. LiveXLive also announced today that SAMF's 10th Anniversary Event will include a virtual live stream component on the heels of the success of this past weekend's virtual SAMF.

iQIYI CMO Vivian Wang Named as One of Asia-Pacific's 50 Most Influential Marketers

iQIYI, Inc. (NASDAQ: IQ) ("iQIYI" or the "Company"), an innovative market-leading online Chinese entertainment service company, is pleased to announce that Vivian Wang, the Company's Chief Marketing Officer and President of its New Consumer Business Group, has been included in Campaign Asia's 2020 Asia-Pacific Power List, which recognizes Asia-Pacific's 50 most influential and purposeful marketers, for her achievements and iQIYI's continued success in entertainment marketing under her leadership.